中国老年保健医学
中國老年保健醫學
중국노년보건의학
CHINESE JOURNAL OF GERIATRIC CARE
2015年
1期
79-80,81
,共3页
茵栀黄注射液%不良反应%文献分析
茵梔黃註射液%不良反應%文獻分析
인치황주사액%불량반응%문헌분석
Yinzhihuang injection%adverse drug reaction%literature analysis
目的:探讨茵栀黄注射液所致不良反应的一般规律及特点,为临床合理用药提供参考。方法计算机检索相关文献数据库中62例描述茵栀黄注射液不良反应的报道,并对其进行分类、统计与分析。结果茵栀黄注射液的不良反应与性别、年龄比例无明显差异,主要为变态反应,严重者可发生过敏性休克。其中全身性损害49例次,占41.18%;呼吸系统损害22例次,占18.49%;皮肤及其附件损害29例次,占24.37%;心脏及外周血管损害3例次,占2.52%;中枢及外周神经系统损害9例次,占7.56%;胃肠系统损害5例次,占4.20%;肝胆系统损害2例次,占1.68%。结论临床应重视茵栀黄注射液的不良反应,加强茵栀黄注射液不良反应的监测,坚持合理用药,确保用药安全有效。
目的:探討茵梔黃註射液所緻不良反應的一般規律及特點,為臨床閤理用藥提供參攷。方法計算機檢索相關文獻數據庫中62例描述茵梔黃註射液不良反應的報道,併對其進行分類、統計與分析。結果茵梔黃註射液的不良反應與性彆、年齡比例無明顯差異,主要為變態反應,嚴重者可髮生過敏性休剋。其中全身性損害49例次,佔41.18%;呼吸繫統損害22例次,佔18.49%;皮膚及其附件損害29例次,佔24.37%;心髒及外週血管損害3例次,佔2.52%;中樞及外週神經繫統損害9例次,佔7.56%;胃腸繫統損害5例次,佔4.20%;肝膽繫統損害2例次,佔1.68%。結論臨床應重視茵梔黃註射液的不良反應,加彊茵梔黃註射液不良反應的鑑測,堅持閤理用藥,確保用藥安全有效。
목적:탐토인치황주사액소치불량반응적일반규률급특점,위림상합리용약제공삼고。방법계산궤검색상관문헌수거고중62례묘술인치황주사액불량반응적보도,병대기진행분류、통계여분석。결과인치황주사액적불량반응여성별、년령비례무명현차이,주요위변태반응,엄중자가발생과민성휴극。기중전신성손해49례차,점41.18%;호흡계통손해22례차,점18.49%;피부급기부건손해29례차,점24.37%;심장급외주혈관손해3례차,점2.52%;중추급외주신경계통손해9례차,점7.56%;위장계통손해5례차,점4.20%;간담계통손해2례차,점1.68%。결론림상응중시인치황주사액적불량반응,가강인치황주사액불량반응적감측,견지합리용약,학보용약안전유효。
Objectives To explore the general rule and the characteristics of adverse drug reaction ( ADR) induced by Yinzhi-huang injection and to provide some references for clinical medicine and rational use of drug .Methods ADR reports induced by Yinzhihuang injection were collected from electronical database and statistically analyzed .Results In 62 cases of the literature , the proportions of age and gender were no significant differences .The main ADR of Yinzhihuang injection were allergic reactions .The serious adverse reaction is allergy shock .In 62 cases, systemic damage 49 cases, account for 41.18%;respiratory system damage 22 cases, account for 18.49%;dermoreaction 29 cases, account for 24.37%;cardiac and peripheral vascular damage 3 cases, ac-count for 2.52%;Central and peripheral nervous system damage 9 cases, account for 7.56%;digestive system damage 5 cases, ac-count for 4.20%;hepatic system damage 2 cases, account for 1.68%.Conclusions We should pay attention to ADR of Yinzhi-huang injection , take more monitoring in the application of Yinzhihuang injection to reduce the occurrence of serious ADR and im -prove the rational use of Yinzhihuang injection in order to ensure that the use of Yinzhihuang injection is safe and effective .